Some of these glycolytic enzymes, as well as other modulators of tumor behavior, have recently been analyzed in search for a clue that inhibition of such enzymes or appropriate tuning of such modulators should deprive tumors of energy, while leaving nontransformed cells unaffected. The gene discussed is HK1; the disease is neoplasm.